Dengue disease, also known as “breakbone fever,” is both the most common and the fastest spreading mosquito-borne virus in the world, affecting nearly 4 billion people worldwide and contributing to up to 36,000 deaths annually. With clinical manifestations ranging from influenza-like symptoms to shock, internal/external bleeding, and even death, it is imperative that clinicians have the knowledge required to promote prevention, diagnosis, and appropriate management of this condition. However, despite recent local outbreaks occurring in Hawaii, Florida, and Texas, clinicians in the United States remain largely unfamiliar with the diagnosis and management of this disease.
In the first activity of this CME Outfitters Snack series, expert faculty will provide learners with the opportunity to grow their knowledge and understanding of the clinical manifestations, transmission, and exposure risks of dengue disease.
Identify the clinical manifestations of dengue disease factoring in exposure risk.
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Physicians, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in travel medicine, public health, infectious disease, or primary care.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Sáfadi reports the following financial relationships:
Advisory Board and Consultant: MSD; Sanofi; and Takeda Pharmaceutical Company Limited
Dr. Esquilín Rivera reports no financial relationships to disclose.
Ms. Garland Negron reports no financial relationships to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:
• Cristina Rivera Carpenter, PhD, MSN, RN (peer reviewer)
• Morgan Stockberger, MD (planning committee)
• John Jones, PharmD (planning committee)
• Susan H. Yarbrough, CHCP (planning committee)
• Sandra Caballero, PharmD (planning committee)
• Sharon Tordoff (planning committee)
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).